These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11936429)

  • 1. Carnitine action on red blood cell osmotic resistance in hemodialysis patients.
    Vlassopoulos DA; Hadjiyannakos DK; Anogiatis AG; Evageliou AE; Santikou AV; Noussias CV; Papandreou PT; Hadjiconstantinou VE
    J Nephrol; 2002; 15(1):68-73. PubMed ID: 11936429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rHuEPO treatment on red blood cell osmotic resistance.
    Mihaljević D; Jakić M; Jakić M; Cetina N; Wagner J; Zibar L; Barbić J
    Coll Antropol; 2004 Dec; 28(2):639-46. PubMed ID: 15666595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
    Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
    Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients.
    Alhomida AS
    Arch Med Res; 1997; 28(1):101-7. PubMed ID: 9078596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients.
    Matsumura M; Hatakeyama S; Koni I; Mabuchi H; Muramoto H
    Nephron; 1996; 72(4):574-8. PubMed ID: 8730424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of haemodialysis on peripheral lymphocyte carnitine levels in patients with chronic pyelonephritis.
    Alhomida AS
    Br J Biomed Sci; 1999; 56(3):194-8. PubMed ID: 10824328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid abnormalities in hemodialysis patients: effect of L-carnitine administration.
    Ahmad S; Dasgupta A; Kenny MA
    Kidney Int Suppl; 1989 Nov; 27():S243-6. PubMed ID: 2636665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
    Reuter SE; Faull RJ; Ranieri E; Evans AM
    Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of nocturnal haemodialysis on carnitine metabolism.
    Hothi DK; Geary DF; Fisher L; Chan CT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2637-41. PubMed ID: 16822785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients.
    Cibulka R; Racek J; Pikner R; Rajdl D; Trefil L; Vesela E; Studenovska M; Siroka R
    Calcif Tissue Int; 2007 Aug; 81(2):99-106. PubMed ID: 17622482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of low carnitine levels in children on dialysis.
    Aguilar-Kitsu A; Ibarra-Cazares P; Mendoza-Guevara L; Villasis-Keever MA; Perez Andrade ME; Castillo-Romero L; Morales-Nava A; Rodriguez-Leyva F; Sanchez-Barbosa L
    Adv Perit Dial; 2006; 22():208-10. PubMed ID: 16983971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
    Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
    Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.